Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26FFF4Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,337
Award facts
- Contract value 100% obligated
- $27,337.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on October 22, 2025, represents a $27,337.46 firm fixed-price contract for Repatha 140 mg/ml SureClick auto-injector medication supplied by AmerisourceBergen Drug Corp to the Defense Logistics Agency (DLA). The contract is a child order under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The award was made on a competitive basis without set-aside designation, reflecting AmerisourceBergen's demonstrated capability to fulfill federal pharmaceutical procurement requirements through open competition.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems. Repatha is a PCSK9 inhibitor used for cholesterol management and cardiovascular disease prevention, representing the type of specialty pharmaceutical products the company regularly supplies through its DLA contracts. The place of performance is located at AmerisourceBergen's Conshohocken facility, with an ultimate completion date of October 23, 2025, indicating expedited delivery requirements typical of federal medical supply orders.
Quick answers
Who was awarded contract SPE2DR26FFF4Q?
SPE2DR26FFF4Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DR26FFF4Q worth?
The government has obligated $27,337 on SPE2DR26FFF4Q.
Is contract SPE2DR26FFF4Q an order under another contract?
Yes. SPE2DR26FFF4Q is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFF4Q competed?
The extent of competition for SPE2DR26FFF4Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award